Seen at the finish of the Plymouth half marathon this morning. Every little helps. [and PS, I was only spectating and cheering on Team Moore]

More than infrequently I wonder what sort of world we inhabit. I'm all for a bit of silliness, but seeing an advertorial in the Times on luxury wedding stationary took this morning's biscuit. It's only a wedding. Send an email.

Is anyone having issues with Octopus Energy billing. Since switching to a fixed Loyalty tariff they keep double charging, and now quadruple charging. They say: 'We believe energy should be better. A better experience for customers,'. I say: 'yeah, right'.

One despairs, really despairs. Free movement for young people would have been terrific for UK and European science.

bbc.co.uk/news/uk-politi…

Very proud of Tim Snyder here - and his work Yale Jackson School and in the public sphere -

Featured: Andrew Moore Christopher Eccleston and co-authors review #cannabidiol ( #CBD ) products for pain.

Put simply, 'there is no good reason for thinking that CBD relieves pain.'

Free, Full Article: jpain.org/article/S1526-…

Love this from JAMA. Community parks initiative with redesign and renovation of neighbourhood parks by the municipal NYC; 33 in the CPI and 22 not. Measured numbers of users over three years. Lots of stats, but who needs them? Green is good
doi:10.1001/jamanetworkopen.2024.1429

CBD Flops Big Time For Pain | American Council on Science and Health

Introducing #CBD (cannabidiol), the latest fad in the ever-expanding universe of pseudo-medicine! It's the 'miracle' cure that's as easy to buy as a candy bar and about as effective as wishing on a shooting…

Instructive to see how THC concentrations in cannabis has changed over time, 67,000 samples here for herbal cannabis, but same for other forms. No change in CBD concentrations over time. Neat SR in Addiction 2020 116:1000.

Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms

Andrew Moore, Sebastian Straube, Emma Fisher Christopher Eccleston

🔎jpain.org/article/S1526-…

Well this is an interesting comment of the recent history of research publishing. It might look different if it was simply the number one could trust, or were worthwhile, or even both.

Top 10 countries with most research paper fb.watch/rfqzQoX3sM/ via facebookwatch

How can this be right? NHSE Board is full of bankers and people with a secondary care background. No patient rep, no primary care rep, no social scientist, no anthropologist etc etc. Leadership body for most expensive public service deserves much much more balance.

You can see their point.

Mixed feelings about closure of UK Cochrane: much good and some irritatingly poor. But Cochrane has tried to be a bulwark against a tidal wave of immensely poor and often misleading SR. Example here of cannabinoids for pain doi.org/10.1097/j.pain….

Early this year I know, but somehow I feel the need to post this:
journals.lww.com/pain/Fulltext/…… #PainEvidence I@PAINTheJournal - this is worth a re-read #painpatientsdeservebetter

Free paper from Cambridge (doi: 10.1192/bjp.2023.91) in BJPsych. Use of cannabis, CBD, and synthetic cannabinoids in >1 in 20 13-14 yo UK teenagers. Worryingly high OR associations between cannabinoid use and adverse mental health conditions. Shout out loud and pass it on.

Former President Barack Obama on why Trump should never be President again. Like and repost the hell out of this.

Thrilled that this has been published. A massive thanks to all the co authors who have been instrumental in getting this over the line. This work provides the starting point to improving pain management for combat injured military personnel.

journals.lww.com/pain/fulltext/…

Free to air today in The Journal of Pain Emma Fisher Christopher Eccleston and Sebastian Straube. We found 15 of 16 RCTs of CBD for pain found no effect at all. Another good RCT in The Lancet since reported no effects. Consumers are being conned by expensive, harmful, quack remedies.

This is a powerful article by George Monbiot in Guardian. Could not escape overtones of this in the world of pain as well, where 'biopsychosocial' is used as a label. I think it may be a label for lack of knowledge and few treatments'.

theguardian.com/commentisfree/…